We are currently in the center of a metabolic revolution where cutting edge science and tech meet consumer driven innovation. With infinite knowledge at consumers’ fingertips, professionals need to understand their personal needs, perceptions and behaviors. Case in point, the exponential use of glucose control devices, like Continuous Glucose Monitors. Thanks to these devices, consumers are increasingly aware that our body’s capacity to maintain a balanced glucose control is constantly being challenged by our modern lifestyle. To address this concern, Rousselot developed Nextida GC, a specific collagen peptide composition that targets the glucose spike after a meal, as shown in a first clinical study. This lecture will be introduced by Ana Cristina Faria, from Rousselot Netherlands.